MD Anderson and Generate: Biomedicines Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI
April 28, 2023
April 28, 2023
HOUSTON, Texas, April 28 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on April 27, 2023:
* * *
Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways traditional techniques cannot
* * *
The University of Texas MD Anderson Cancer Center and Generate:Biomedicines today announced a strategic collaboration to jointly discove . . .
* * *
Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways traditional techniques cannot
* * *
The University of Texas MD Anderson Cancer Center and Generate:Biomedicines today announced a strategic collaboration to jointly discove . . .